This article is part of the supplement: B cell targeted therapy: a new approach to the treatment of rheumatoid arthritis

Highly Accessed Email this article to a friend

B cell non-Hodgkin's lymphoma: rituximab safety experience

Ann Mohrbacher

Arthritis Research & Therapy 2005, 7(Suppl 3):S19-S25 doi:10.1186/ar1739

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.
How can I ensure that I receive Arthritis Research & Therapy's emails?